Pharmaversity®

Discover how prefilled syringes withstand ultra-cold storage from -80°C to -180°C without compromising integrity. Join our webinar to explore key insights on container closure integrity, silicone distribution, and mechanical performance—proven stable under extreme conditions. Learn about testing methods, critical data, and what this means for the future of cell and gene cold chain solutions.

Learn more about your ad choices. Visit megaphone.fm/adchoices

When it comes to drug containment, not only the stability of the drug plays a crucial role, but also the stability of the container itself - an optimized geometry can help to avoid breakage, during fill-and-finish as well as during storage. Resulting in safeguarding the patient and improving efficiency.

In addition, high rejections rates due to cosmetic defects or due to fogging during lyophilization also result in elevated costs - even more crucial if high value drugs are affected.

This Pharmaversity session will demonstrate how the choice of the vial can contribute to improve fill-and-finish efficiency and which parameters need to be considered. 

Learn more about your ad choices. Visit megaphone.fm/adchoices

Good-quality pharmaceutical containers are not only a prerequisite for the safe storage and delivery of drug products, but they also have a positive impact on fill-and-finish processes. The more uniform a container is, the smoother it runs on the fill-and-finish line, resulting in lower container-related rejection rates. In this Pharmaversity session you will get insights on how you can unlock fill-and-finish Excellence with Core Vials.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Prefilled polymer syringes have significantly enhanced the safety and effectiveness of infusion therapy in hospitals, moving away from traditional vial-and-syringe systems. Despite these advancements, hospitals still encounter various challenges, such as high drug waste due to unclear packaging, manual tray preparation, and storage issues. Additionally, pharmaceutical manufacturers face stringent regulatory requirements that can delay the development of combination products.

Join our webinar to explore an innovative solution that addresses these challenges, improving operational efficiency, ensuring long shelf-life efficacy, and accelerating time to market.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Climate change stands as one of the most pressing challenges of our time, demanding innovative solutions to decarbonize production and supply chains globally. Over 7,000 companies, including 19 of the top 20 pharmaceutical firms, have committed to science-based targets to ensure a reliable and scientific approach to this issue.

It's time to share a blueprint for drastically reducing emissions with a broader audience. Join our webinar to discover the future-proof pharma glass tubing, FIOLAX® Pro. Learn how this innovative electrified melting technology reduces the CO2 footprint of primary packaging containers, paving the way for a sustainable future.

Learn more about your ad choices. Visit megaphone.fm/adchoices

The integrity of pharmaceutical packaging is vital, especially for biologics, where drug-container interactions can significantly impact stability and efficacy. In the upcoming webinar we will explore key considerations in selecting and optimizing ready-to-use (RTU) cartridges for complex drug formulations. Topics include material compatibility, leachable profiles, and strategies to mitigate risks such as delamination. We will also discuss drug-container interactions and their implications for long-term storage. Additionally, critical performance parameters like break-loose gliding force (BLGF) and functional stability will be covered to ensure seamless drug administration.

Join the webinar to gain valuable insights into optimizing packaging solutions for the next generation of drug delivery systems with RTU cartridges.

Learn more about your ad choices. Visit megaphone.fm/adchoices

The pharmaceutical industry continues to trend towards large volume subcutaneous drug formulations, accompanied by a strong emphasis on simplifying drug administration. However, dosage volumes of 10 mL and higher present specific challenges, including limited availability of qualified primary packaging, shortcomings in On Body Devices, and the drawbacks of manual push drug administration.

The SCHOTT TOPPAC® COC polymer pre-fillable syringes, in combination with KORU’s Near Body Devices, effectively address these challenges, particularly in the 10 to 50 mL volume range.

Join this Pharmaversity session to discover how this integrated system:

- Mitigates risks in development and routine drug administration

- Enhances user experience for healthcare professionals and self-administration

- Accelerates time to market

- Contributes to sustainability efforts

Learn more about your ad choices. Visit megaphone.fm/adchoices

Despite advancements in subcutaneous (SC) autoinjection, comprehensive insights are still limited. SC delivery of biologics faces challenges such as drug volume, viscosity, and user injection time. While adjunct molecules have improved absorption for larger doses, significant gaps remain in SC drug development.

Join this joint webinar by SHL Medical and SCHOTT Pharma, where we will present findings from a literature review, feasibility testing of 60-second injections, and characterization of 5.0 mL cartridges. These studies are designed to deepen understanding and drive progress in large-volume autoinjection delivery.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Primary packaging is a crucial component of drug formulation. Even the most advanced medication can lose its efficacy if stored in a container that fails to maintain its stability over time.

With the growing prevalence of biologics, the range of molecules and applications continues to expand, leading to increasingly diverse requirements for primary packaging. For example, more than 50% of biologics require lyophilization, which can introduce challenges such as "fogging." Additionally, some molecules are highly sensitive to glass leachables, particularly with low-fill volumes, while others may adsorb to the container's surface, affecting dosage accuracy or necessitating overfilling.

At SCHOTT Pharma, we offer the most extensive range of vial solutions designed to address these specific challenges. Join our upcoming webinar to explore our advanced vial solutions, tailored to meet the demands of next-generation drugs.

Learn more about your ad choices. Visit megaphone.fm/adchoices

The use of biologics is a rapidly growing field in the treatment of chronic diseases, both in hospitals and through patient self-medication at home. Pharma companies' development pipelines for injectable biologics are well-filled, projecting a high demand for high-end container solutions. These solutions must be robust and reliable to address the numerous challenges of biologics, such as drug-container interactions, particles, and functional requirements.

In this joint Pharmaversity® session with Datwyler, we will explore how the syriQ BioPure® prefillable glass syringe (PFS) platform and the spray-coated NeoFlex™ plunger portfolio are addressing stakeholder needs in biologics - from pharmaceutical requirements to user needs and processability, including important topics like drug compatibility, device integration, supply chain security, sustainability, and the latest regulatory considerations.  

Learn more about your ad choices. Visit megaphone.fm/adchoices